I agree that this site is using cookies. You can find further informations here.
X
Samineni, Divya
16  results:
OpenAccess-fulltext X
Search for persons X
?
1

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients wi..:

Herrera, Alex F ; Patel, Manish R ; Burke, John M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365381/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
2

Pharmacokinetics and Exposure-Response Analysis of Venetocl..:

Samineni, Divya ; Gibiansky, Leonid ; Wang, Bei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309146/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Bioavailability Evaluation of Venetoclax Lower-Strength Tab..:

Badawi, Mohamed ; Chen, Xin ; Marroum, Patrick...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338003/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

A Phase I dose‐escalation study of DCLL9718S, an antibody‐d..:

Daver, Naval ; Salhotra, Amandeep ; Brandwein, Joseph M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252033/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Population Pharmacokinetics and Exposure–Response Analyses ..:

Samineni, Divya ; Huang, Weize ; Gibiansky, Leonid...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799559/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

A phase 2 study of venetoclax plus R-CHOP as first-line tre..:

Morschhauser, Franck ; Feugier, Pierre ; Flinn, Ian W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869186/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Model‐Informed Therapeutic Dose Optimization Strategies for..:

Liao, Michael Z ; Lu, Dan ; Kågedal, Matts...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596428/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Impact of Physiologically Based Pharmacokinetics, Populatio..:

Li, Chunze ; Chen, Shang‐Chiung ; Chen, Yuan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756373/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
9

Time‐to‐Event Modeling of Peripheral Neuropathy: Platform A..:

Kågedal, Matts ; Samineni, Divya ; Gillespie, William R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709423/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
10

Phase I study of the anti-FcRH5 antibody-drug conjugate DFR..:

Stewart, A. Keith ; Krishnan, Amrita Y ; Singhal, Seema...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362066/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
11

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: resul..:

Zelenetz, Andrew D ; Salles, Gilles ; Mason, Kylie D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497517/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
12

A randomized trial of the efficacy and safety of quilizumab..:

Harris, Jeffrey ; Maciuca, Romeo ; Bradley, Mary...
http://respiratory-research.com/content/17/1/29.  , 2016
Link: http://respiratory-resea..
 
?
13

Brain distribution and elimination of recombinant human TIM..:

Sa, Yalian ; Hao, Jinsong ; Samineni, Divya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193946.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
14

Clinical pharmacology of vc-MMAE antibody–drug conjugates i..:

Chunze Li ; Cindy Zhang ; Zao Li...
https://www.tandfonline.com/doi/10.1080/19420862.2019.1699768.  , 2020
Link: https://doi.org/10.1080/..
 
?
15

Prediction of Human Pharmacokinetics of Antibody–Drug Conju..:

Chunze Li ; Cindy Zhang ; Rong Deng...
https://doi.org/10.1111/cts.12649.  , 2019
Link: https://doi.org/10.1111/..
 
1-15